Thomas J Herzog Selected Research

Topoisomerase I Inhibitors

5/2008	Key role of topoisomerase I inhibitors in the treatment of recurrent and refractory epithelial ovarian carcinoma.
7/2004	The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model.
1/2002	Update on the role of topotecan in the treatment of recurrent ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas J Herzog Research Topics

Disease

76	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 01/2002
60	Neoplasms (Cancer) 01/2022 - 03/2002
23	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 06/2003
18	Endometrial Neoplasms (Endometrial Cancer) 09/2015 - 06/2002
15	Carcinoma (Carcinomatosis) 10/2019 - 01/2002
12	Ovarian Epithelial Carcinoma 01/2020 - 01/2004
6	Neutropenia 02/2017 - 01/2002
6	Ascites 06/2015 - 01/2002
5	Neoplasm Metastasis (Metastasis) 04/2017 - 03/2004
5	Hypertension (High Blood Pressure) 01/2017 - 11/2004
4	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 12/2004
4	Disease Progression 01/2020 - 09/2003
4	Fatigue 02/2017 - 10/2014
4	Thrombocytopenia (Thrombopenia) 10/2014 - 01/2002
4	Lymphatic Metastasis 12/2004 - 06/2003
3	Infections 01/2017 - 11/2004
3	Febrile Neutropenia 01/2017 - 01/2004
3	Hemorrhage 07/2014 - 08/2013
3	Wounds and Injuries (Trauma) 10/2013 - 06/2010
3	Venous Thromboembolism 11/2011 - 06/2010
2	Fallopian Tube Neoplasms 12/2021 - 01/2017
2	Fever (Fevers) 01/2021 - 11/2014
2	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 07/2020 - 11/2004
2	Uterine Neoplasms (Uterine Cancer) 01/2020 - 07/2013
2	COVID-19 01/2020 - 01/2020
2	Leiomyosarcoma 12/2018 - 11/2008
2	Nausea 02/2017 - 11/2014
2	Vomiting 02/2017 - 11/2014
2	Proteinuria 01/2017 - 07/2014
2	Endometriosis 01/2016 - 08/2013
2	Abdominal Pain (Pain, Abdominal) 11/2014 - 07/2014
2	Female Genital Diseases 05/2014 - 02/2013
2	Pelvic Organ Prolapse 08/2013 - 11/2012
2	Vulvar Neoplasms (Vulvar Cancer) 07/2013 - 09/2008
2	Adenocarcinoma 01/2012 - 12/2007
2	Clear Cell Adenocarcinoma 01/2009 - 12/2004
2	Carcinosarcoma 11/2008 - 07/2008
2	Hemolytic-Uremic Syndrome 04/2005 - 11/2004
2	Anemia 11/2004 - 01/2002
1	Microsatellite Instability 01/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2019
1	Starvation 01/2019

Drug/Important Bio-Agent (IBA)

26	PlatinumIBA 05/2022 - 01/2002
16	liposomal doxorubicin (Doxil)FDA Link 11/2021 - 01/2002
14	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 01/2002
12	Biomarkers (Surrogate Marker)IBA 12/2021 - 06/2010
11	Topotecan (Hycamtin)FDA LinkGeneric 03/2011 - 01/2002
10	1-dodecylpyridoxal (PLD)IBA 11/2021 - 04/2005
10	Carboplatin (JM8)FDA LinkGeneric 12/2020 - 01/2004
8	Pharmaceutical PreparationsIBA 11/2021 - 07/2005
7	TrabectedinIBA 01/2021 - 07/2010
7	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2004
6	Bevacizumab (Avastin)FDA Link 05/2022 - 11/2010
6	taxaneIBA 01/2017 - 08/2006
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2019
4	Hormones (Hormone)IBA 01/2020 - 06/2010
4	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 07/2004
4	Gemcitabine FDA Link 03/2010 - 01/2004
4	VaccinesIBA 05/2008 - 09/2003
4	Deoxyglucose (2 Deoxy D glucose)IBA 12/2005 - 06/2003
3	FANG vaccineIBA 12/2021 - 12/2020
3	Docetaxel (Taxotere)FDA Link 03/2014 - 08/2003
3	Topoisomerase I InhibitorsIBA 05/2008 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 12/2007 - 06/2002
2	Monoclonal AntibodiesIBA 12/2021 - 01/2016
2	AntigensIBA 04/2017 - 07/2016
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2016 - 01/2016
2	pazopanib FDA Link 03/2016 - 10/2014
2	Progestins (Progestagens)IBA 09/2015 - 01/2004
2	Phosphotransferases (Kinase)IBA 07/2013 - 02/2013
2	Etoposide (VP 16)FDA LinkGeneric 11/2004 - 11/2004
1	Poly Adenosine Diphosphate RiboseIBA 05/2022
1	Immune Checkpoint InhibitorsIBA 12/2021
1	NivolumabIBA 12/2021
1	rucaparibIBA 12/2021
1	EpitopesIBA 12/2021
1	Death Domain ReceptorsIBA 12/2021
1	Alkylating AgentsIBA 01/2021
1	Chloroquine (Aralen)FDA LinkGeneric 01/2019

Therapy/Procedure

49	Therapeutics 05/2022 - 01/2002
30	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
28	Hysterectomy 10/2021 - 08/2004
9	Radiotherapy 08/2014 - 09/2003
8	Lymph Node Excision (Lymph Node Dissection) 01/2013 - 04/2002
5	Immunotherapy 01/2022 - 01/2019
4	Ovariectomy (Oophorectomy) 10/2021 - 04/2002
4	Laparotomy 11/2004 - 03/2004
3	Cytoreduction Surgical Procedures 12/2021 - 12/2011
3	Adjuvant Chemotherapy 01/2019 - 10/2018
3	Brachytherapy 08/2014 - 12/2011
3	Neoadjuvant Therapy 04/2014 - 09/2008
3	Adjuvant Radiotherapy 04/2009 - 10/2003
2	Precision Medicine 01/2022 - 06/2012
2	Length of Stay 06/2010 - 09/2003
2	Aftercare (After-Treatment) 01/2007 - 11/2004
2	Catheters 05/2006 - 01/2002
1	Tubal Sterilization (Tubal Ligation) 10/2021
1	Salpingectomy 10/2021
1	Intravenous Infusions 01/2020
1	Treatment Delay 10/2018